Concepedia
Statistics
Publications
4
Citations
290
H-Index
Active since
2010
Affiliations
Takeda (United States)(Current)
Millennium Engineering and Integration (United States)
Roushan Afroze is an author at Takeda (United States) specializing in pharmacy, drug discovery, and medicinal chemistry.
Publications per year
2010–2021
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
Steven Langston, Stephen Grossman, Dylan B. England et al. · Journal of Medicinal Chemistry · 2021 · 208 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +11
Microwave-accelerated fluorodenitrations and nitrodehalogenations: expeditious routes to labeled PET ligands and fluoropharmaceuticals
Paul LaBeaume, Michael S. Placzek, Mathew P. Daniels et al. · Tetrahedron Letters · 2010 · 39 citations
Medicine, Chemistry, Nuclear Medicine +5
Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors
Alexandra E. Gould, Ruth Adams, Sharmila Adhikari et al. · Journal of Medicinal Chemistry · 2011 · 33 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERG
Shih‐Chung Huang, Sharmila Adhikari, Roushan Afroze et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 10 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
1–4 of 4